Published in Nature on January 27, 1994
Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci U S A (2002) 4.66
The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J (2002) 2.41
On the structural basis for ionic selectivity among Na+, K+, and Ca2+ in the voltage-gated sodium channel. Biophys J (1996) 2.39
The toxicity in vitro of beta-amyloid protein. Biochem J (1995) 2.17
Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature (2008) 1.88
Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci U S A (1995) 1.83
Serum amyloid P inhibits fibrosis through Fc gamma R-dependent monocyte-macrophage regulation in vivo. Sci Transl Med (2009) 1.74
VIP36, a novel component of glycolipid rafts and exocytic carrier vesicles in epithelial cells. EMBO J (1994) 1.67
Narp regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons. Nat Neurosci (2010) 1.54
The function of activity-regulated genes in the nervous system. Physiol Rev (2009) 1.54
FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation. J Leukoc Biol (2012) 1.54
Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Ann Rheum Dis (2005) 1.48
Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc Natl Acad Sci U S A (2000) 1.47
Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae. PLoS Pathog (2007) 1.46
Amyloid accomplices and enforcers. Protein Sci (2004) 1.36
Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci U S A (1994) 1.35
mGluR1/5-dependent long-term depression requires the regulated ectodomain cleavage of neuronal pentraxin NPR by TACE. Neuron (2008) 1.31
Mutational analysis of the neurexin/neuroligin complex reveals essential and regulatory components. Proc Natl Acad Sci U S A (2008) 1.28
Pentraxins: structure, function, and role in inflammation. ISRN Inflamm (2013) 1.23
Protective molecules--C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity. J Clin Immunol (2005) 1.23
Symmetry, stability, and dynamics of multidomain and multicomponent protein systems. Proc Natl Acad Sci U S A (1996) 1.22
Pattern recognition by pentraxins. Adv Exp Med Biol (2009) 1.19
The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2. J Biol Chem (2010) 1.13
Crystal structure of human sex hormone-binding globulin: steroid transport by a laminin G-like domain. EMBO J (2000) 1.12
The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo. J Clin Invest (1994) 1.11
Insight into a conserved lifestyle: protein-carbohydrate adhesion strategies of vector-borne pathogens. Infect Immun (2005) 1.05
Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system. J Biol Chem (2010) 0.96
Pathogen recognition by the long pentraxin PTX3. J Biomed Biotechnol (2011) 0.94
High-throughput biophysical analysis of protein therapeutics to examine interrelationships between aggregate formation and conformational stability. AAPS J (2013) 0.94
Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation. Infect Immun (2000) 0.93
Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease. Mol Neurobiol (2007) 0.92
Pentraxins and Fc receptors. Immunol Rev (2012) 0.92
SAP suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. Immunol Cell Biol (2011) 0.92
Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS. Infect Immun (1999) 0.91
Amelioration of lupus nephritis by serum amyloid P component gene therapy with distinct mechanisms varied from different stage of the disease. PLoS One (2011) 0.89
The "sweet" side of a long pentraxin: how glycosylation affects PTX3 functions in innate immunity and inflammation. Front Immunol (2013) 0.85
Accumulation and expression of serum amyloid P component in human atherosclerotic lesions. Atherosclerosis (2010) 0.85
Antibody-array interaction mapping, a new method to detect protein complexes applied to the discovery and study of serum amyloid P interactions with kininogen in human plasma. Mol Cell Proteomics (2009) 0.84
Pentraxin 3 in amniotic fluid: a novel association with intra-amniotic infection and inflammation. J Perinat Med (2010) 0.84
Correlations between pentraxin 3 or cytokine levels in gingival crevicular fluid and clinical parameters of chronic periodontitis. Odontology (2011) 0.84
Human scleral elastic system: an immunoelectron microscopic study. Br J Ophthalmol (1995) 0.84
Investigating interactions of the pentraxins serum amyloid P component and C-reactive protein by mass spectrometry. Biochem J (2003) 0.84
Inhibition of TTR aggregation-induced cell death--a new role for serum amyloid P component. PLoS One (2013) 0.81
Increased expression of long pentraxin PTX3 in inflammatory bowel diseases. Dig Dis Sci (2007) 0.81
Effects of succinylation on thermal induced amyloid formation in Concanavalin A. Eur Biophys J (2007) 0.81
Serum amyloid P component prevents high-density lipoprotein-mediated neutralization of lipopolysaccharide. Infect Immun (2000) 0.81
The phosphocholine-binding pocket on C-reactive protein is necessary for initial protection of mice against pneumococcal infection. J Biol Chem (2012) 0.81
Lipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2. PLoS One (2011) 0.81
The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling. J Hepatol (2016) 0.80
Brain serum amyloid P levels are reduced in individuals that lack dementia while having Alzheimer's disease neuropathology. Neurochem Res (2011) 0.80
The major acute-phase protein, serum amyloid P component, in mice is not involved in endogenous resistance against tumor necrosis factor alpha-induced lethal hepatitis, shock, and skin necrosis. Infect Immun (2000) 0.79
Pentraxin 3 in maternal circulation: an association with preterm labor and preterm PROM, but not with intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med (2010) 0.79
Glycoproteins of drusen and drusen-like lesions. J Mol Histol (2007) 0.79
Unlocked concanavalin A forms amyloid-like fibrils from coagulation of long-lived "crinkled" intermediates. PLoS One (2013) 0.78
Genetic deletion of NP1 prevents hypoxic-ischemic neuronal death via reducing AMPA receptor synaptic localization in hippocampal neurons. J Am Heart Assoc (2013) 0.78
Human SAP is a novel peptidoglycan recognition protein that induces complement-independent phagocytosis of Staphylococcus aureus. J Immunol (2013) 0.78
Innate immunity, hemostasis and matrix remodeling: PTX3 as a link. Semin Immunol (2016) 0.77
Relationship of Inflammatory Biomarkers with Severity of Peripheral Arterial Disease. Int J Vasc Med (2016) 0.77
Crystal structure of the tetrameric fibrinogen-like recognition domain of fibrinogen C domain containing 1 (FIBCD1) protein. J Biol Chem (2013) 0.77
From local structure to a global framework: recognition of protein folds. J R Soc Interface (2014) 0.76
Computational analysis of C-reactive protein for assessment of molecular dynamics and interaction properties. Cell Biochem Biophys (2013) 0.76
Pentraxins and IgA share a binding hot-spot on FcαRI. Protein Sci (2014) 0.75
Comparison between intact and desialylated human serum amyloid P component by laser photo CIDNP (chemically induced dynamic nuclear polarization) technique: an indication for a conformational impact of sialic acid. Glycoconj J (1997) 0.75
The Potential Role of Aerobic Exercise-Induced Pentraxin 3 on Obesity-Related Inflammation and Metabolic Dysregulation. Mediators Inflamm (2017) 0.75
Surface induced dissociation yields substructure of Methanosarcina thermophila 20S proteasome complexes. Int J Mass Spectrom (2015) 0.75
Sulphatide-binding properties are shared by serum amyloid P component and a polyreactive germ-line IgM autoantibody, the TH3 idiotype. Clin Exp Immunol (1998) 0.75
Interaction of serum amyloid P component with hexanoyl bis(D-proline) (CPHPC). Acta Crystallogr D Biol Crystallogr (2014) 0.75
Topological mimicry and epitope duplication in the guanylyl cyclase C receptor. Protein Sci (1998) 0.75
Serum Amyloid P Component Ameliorates Neurological Damage Caused by Expressing a Lysozyme Variant in the Central Nervous System of Drosophila melanogaster. PLoS One (2016) 0.75
Protective molecules and their cognate antibodies: new players in autoimmunity. Auto Immun Highlights (2010) 0.75
Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol (1993) 64.61
FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. J Mol Biol (2001) 10.02
The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med (1994) 8.10
Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol (1983) 7.47
Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol (1997) 7.27
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ (2000) 6.10
C-reactive protein fifty years on. Lancet (1981) 5.93
HOMSTRAD: a database of protein structure alignments for homologous families. Protein Sci (1998) 5.62
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature (1997) 5.47
The TRANSPARENT TESTA GLABRA1 locus, which regulates trichome differentiation and anthocyanin biosynthesis in Arabidopsis, encodes a WD40 repeat protein. Plant Cell (1999) 4.54
Doublets of Stripped Atoms of the Potassium Type. Proc Natl Acad Sci U S A (1926) 4.37
Particulate air pollution is associated with an acute phase response in men; results from the MONICA-Augsburg Study. Eur Heart J (2001) 4.21
JOY: protein sequence-structure representation and analysis. Bioinformatics (1998) 4.10
Definition of general topological equivalence in protein structures. A procedure involving comparison of properties and relationships through simulated annealing and dynamic programming. J Mol Biol (1990) 4.02
Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature (2000) 3.90
Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med (1999) 3.88
Knowledge based modelling of homologous proteins, Part I: Three-dimensional frameworks derived from the simultaneous superposition of multiple structures. Protein Eng (1989) 3.79
Stripped Atoms of the First Long Period. Proc Natl Acad Sci U S A (1926) 3.41
Adverse outcomes and lack of health insurance among newborns in an eight-county area of California, 1982 to 1986. N Engl J Med (1989) 3.35
The structure of 2Zn pig insulin crystals at 1.5 A resolution. Philos Trans R Soc Lond B Biol Sci (1988) 3.30
A database of globular protein structural domains: clustering of representative family members into similar folds. Fold Des (1996) 3.23
Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. N Engl J Med (1990) 3.17
Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin Exp Immunol (1978) 3.06
PIC: Protein Interactions Calculator. Nucleic Acids Res (2007) 3.02
Knowledge-based prediction of protein structures and the design of novel molecules. Nature (1987) 2.99
Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest (1993) 2.92
Role of complement in induction of the allergic response. Nat New Biol (1972) 2.90
Conformation of beta-hairpins in protein structures. A systematic classification with applications to modelling by homology, electron density fitting and protein engineering. J Mol Biol (1989) 2.86
Standardized definitions of molecular response in chronic myeloid leukemia. Leukemia (2012) 2.80
Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta (1981) 2.77
SUPFAM: a database of sequence superfamilies of protein domains. BMC Bioinformatics (2004) 2.72
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature (2002) 2.71
Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet (2001) 2.71
Activation of mouse complement by different classes of mouse antibody. Immunology (1979) 2.68
The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure (1999) 2.64
Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care (2000) 2.63
Environment-specific amino acid substitution tables: tertiary templates and prediction of protein folds. Protein Sci (1992) 2.61
A six-stranded double-psi beta barrel is shared by several protein superfamilies. Structure (1999) 2.57
Tertiary structural constraints on protein evolutionary diversity: templates, key residues and structure prediction. Proc Biol Sci (1990) 2.53
Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis. Vet Parasitol (2009) 2.52
Effect of alcohol consumption on systemic markers of inflammation. Lancet (2001) 2.52
Hsp26: a temperature-regulated chaperone. EMBO J (1999) 2.51
Serum amyloid P-component is an acute-phase reactant in the mouse. Nature (1979) 2.49
Complement dependence of localisation of aggregated IgG in germinal centres. Scand J Immunol (1975) 2.48
Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest (1982) 2.48
New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor. Nature (1991) 2.47
Structural evidence for gene duplication in the evolution of the acid proteases. Nature (1978) 2.47
Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J Exp Med (1974) 2.45
Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease. Gastroenterology (1983) 2.37
Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. J Exp Med (1982) 2.33
Atomic positions in rhombohedral 2-zinc insulin crystals. Nature (1971) 2.31
Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum (1997) 2.31
Role of C3 in in vitro lymphocyte cooperation. Nature (1974) 2.27
C-reactive protein and coronary heart disease: a critical review. J Intern Med (2008) 2.25
Rubidium and Caesium-Like Doublets of Stripped Atoms. Proc Natl Acad Sci U S A (1926) 2.22
X-ray analysis of beta B2-crystallin and evolution of oligomeric lens proteins. Nature (1990) 2.21
Role of complement in the induction of immunological responses. Transplant Rev (1976) 2.21
Evolutionary trace analysis of TGF-beta and related growth factors: implications for site-directed mutagenesis. Protein Eng (2000) 2.20
Location of a folding protein and shape changes in GroEL-GroES complexes imaged by cryo-electron microscopy. Nature (1994) 2.19
Analogues in other mammals and in fish of human plasma proteins, C-reactive protein and amyloid P component. Nature (1978) 2.18
Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease. Gastroenterology (1997) 2.18
C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med (1999) 2.17
Isolation of human C-reactive protein and serum amyloid P component. J Immunol Methods (1982) 2.15
Receptor-binding region of insulin. Nature (1976) 2.14
Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet (1982) 2.10
Amyloidosis. Histopathology (1994) 2.10
Isolation of amyloid P component (protein AP) from normal serum as a calcium-dependent binding protein. Lancet (1977) 2.09
Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol (1979) 2.08
Crystal structure of an Xrcc4-DNA ligase IV complex. Nat Struct Biol (2001) 2.07
Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J (1982) 2.07
Chlamydia trachomatis infection in women: a need for universal screening in high prevalence populations? Am J Epidemiol (1992) 2.07
Isolation of serum amyloid P-component (protein SAP) in the mouse. Immunology (1979) 2.07
Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1. Infect Immun (2000) 2.07
Phylogenetic aspects of C-reactive protein and related proteins. Ann N Y Acad Sci (1982) 2.03
Displacement of Certain Multiplets and Multiple Levels for Elements in the First Long Period. Proc Natl Acad Sci U S A (1927) 2.00
Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat Med (2001) 1.99
Stereochemical modeling of disulfide bridges. Criteria for introduction into proteins by site-directed mutagenesis. Protein Eng (1989) 1.98
Isolation of C-reactive protein by affinity chromatography. Clin Exp Immunol (1977) 1.97
HOMSTRAD: adding sequence information to structure-based alignments of homologous protein families. Bioinformatics (2001) 1.97
Alignment and searching for common protein folds using a data bank of structural templates. J Mol Biol (1993) 1.97
C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM (2003) 1.93
Crystal structure of aspartate decarboxylase at 2.2 A resolution provides evidence for an ester in protein self-processing. Nat Struct Biol (1998) 1.89
Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J (1999) 1.87
Three dimensional structure of human C-reactive protein. Nat Struct Biol (1996) 1.87
A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum. Vet Rec (1997) 1.86
Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci U S A (1995) 1.83
Comparison of solvent-inaccessible cores of homologous proteins: definitions useful for protein modelling. Protein Eng (1987) 1.81
C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation (2001) 1.81
Structural basis of allosteric changes in the GroEL mutant Arg197-->Ala. Nat Struct Biol (1997) 1.80
Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component. J Exp Med (1998) 1.78
A novel variant of transthyretin, 59Thr-->Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family. Circulation (1995) 1.77
Pentameric and decameric structures in solution of serum amyloid P component by X-ray and neutron scattering and molecular modelling analyses. J Mol Biol (1997) 1.77
Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis (1980) 1.76